Patent foramen ovale closure with the intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 3, 2008, Pages 390-395

  Spies, Christian ^a   Timmermanns, Ines ^b   Reissmann, Ulrich ^c   Van Essen, Jörg ^d   Schräder, Rainer ^b,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^c AGAPLESION MARKUS KRANKENHAUS   (Germany)

^d Medizinischer Dienst der Krankenversicherung in Hessen   (Germany)

Author keywords

Cryptogenic stroke; Structural heart disease; Transcatheter closure

Indexed keywords

FLECAINIDE;

ADULT; AGED; AIR EMBOLISM; ARTICLE; CEREBROVASCULAR DISEASE; CONSCIOUS SEDATION; CONTROLLED STUDY; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PERICARDIAL EFFUSION; SUPRAVENTRICULAR TACHYCARDIA; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGE FACTORS; AGED; BALLOON OCCLUSION; COHORT STUDIES; EMBOLISM, PARADOXICAL; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 41149143245     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21383     Document Type: Article

References (19)

1. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
2. Spies C, Strasheim R, Timmermanns I, Schraeder R. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder. Eur Heart J 2006;27: 365-371.
3. Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios IF, Lang P. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311-1316.
4. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, Giamberti A, Pome G, Bossone E, Frigiola A. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-1065.
5. Mullen MJ, Hildick-Smith D, De Giovanni JV, Duke C, Hillis WS, Morrison WL, Jux C. BioSTAR Evaluation STudy (BEST): A prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation 2006;114:1962-1967.
6. Donti A, Giardini A, Salomone L, Formigari R, Picchio FM. Transcatheter patent foramen ovale closure using the premere PFO occlusion system. Catheter Cardiovasc Interv 2006;68:736-740.
7. Sievert H, Babic UU, Hausdorf G, Schneider M, Hopp HW, Pfeiffer D, Pfisterer M, Friedli B, Urban P. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 1998; 82:1405-1413.
8. Chatterjee T, Petzsch M, Ince H, Rehders TC, Korber T, Weber F, Schneider H, Auf der MC, Nienaber CA. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism. J Interv Cardiol 2005;18:173-179.
9. Schrader R. Indication and techniques of transcatheter closure of patent foramen ovale. J Interv Cardiol 2003;16:543-551.
10. Guerin P, Lambert V, Godart F, Legendre A, Petit J, Bourlon F, De GB, Petit A, Monrozier B, Rossignol AM, Jimenez M, Crochet D, Choussat A, Rey C, Losay J. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: Results of a multicentric French registry. Cardiovasc Intervent Radiol 2005;28:164-168.
11. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004;43:302-309.
12. Carminati M, Chessa M, Butera G, Bini RM, Giusti S, Festa P, Spadoni I, Redaelli S, Hausdorf G. Transcatheter closure of atrial septal defects with the STARFlex device: Early results and follow-up. J Interv Cardiol 2001;14:319-324.
13. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review. Ann Intern Med 2003;139:753-760.
14. Onorato E, Melzi G, Casilli F, Pedon L, Rigatelli G, Carrozza A, Maiolino P, Zanchetta M, Morandi E, Angeli S, Anzola GP. Patent foramen ovale with paradoxical embolism: Mid-term results of transcatheter closure in 256 patients. J Interv Cardiol 2003;16:43-50.
15. Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King ME, Buonanno F, Demirjian Z, de Moor M, Palacios IF. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126.
16. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
17. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C, Meier B. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
18. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44: 750-758.
19. Heinisch C, Baranowski A, Majunke N, Skowasch M., Fischer E, Leetz M, Wunderlich N, Sievert H. Single center results of PFO closure without an implantable device. Circulation 2006;114(18, Suppl II):386 (Abstract).